Stock Research for KMDA

KMDA
Current Price

$5.2500


Latest Update: 2018-02-16 16:00:00

High
$ 5.2500
Low
$ 5.2500
Close
$ 5.2500
Volume
463
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

KMDA Stock Chart & Research Data

The KMDA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the KMDA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


KMDA Due diligence Resources & Stock Charts

The KMDA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View KMDA Detailed Price Forecast - CNN Money CNN View KMDA Detailed Summary - Google Finance
Yahoo View KMDA Detailed Summary - Yahoo! Finance Zacks View KMDA Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View KMDA Trends & Analysis - Trade-Ideas Barrons View KMDA Major Holders - Barrons
NASDAQ View KMDA Call Transcripts - NASDAQ Seeking View KMDA Breaking News & Analysis - Seeking Alpha
Spotlight View KMDA Annual Report - CompanySpotlight.com OTC Report View KMDA OTC Short Report - OTCShortReport.com
TradeKing View KMDA Fundamentals - TradeKing Charts View KMDA SEC Filings - Bar Chart
WSJ View Historical Prices for KMDA - The WSJ Morningstar View Performance/Total Return for KMDA - Morningstar
MarketWatch View the Analyst Estimates for KMDA - MarketWatch CNBC View the Earnings History for KMDA - CNBC
StockMarketWatch View the KMDA Earnings - StockMarketWatch MacroAxis View KMDA Buy or Sell Recommendations - MacroAxis
Bullish View the KMDA Bullish Patterns - American Bulls Short Pains View KMDA Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View KMDA Stock Mentions - StockTwits PennyStocks View KMDA Stock Mentions - PennyStockTweets
Twitter View KMDA Stock Mentions - Twitter Invest Hub View KMDA Investment Forum News - Investor Hub
Yahoo View KMDA Stock Mentions - Yahoo! Message Board Seeking Alpha View KMDA Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for KMDA - SECform4.com Insider Cow View Insider Transactions for KMDA - Insider Cow
CNBC View KMDA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for KMDA - OTC Markets
Yahoo View Insider Transactions for KMDA - Yahoo! Finance NASDAQ View Institutional Holdings for KMDA - NASDAQ


Stock Charts

FinViz View KMDA Stock Insight & Charts - FinViz.com StockCharts View KMDA Investment Charts - StockCharts.com
BarChart View KMDA Stock Overview & Charts - BarChart Trading View View KMDA User Generated Charts - Trading View


Latest Financial News for KMDA

Kamada posts 4Q profit
Posted on Wednesday February 07, 2018

On a per-share basis, the Ness Ziona, Israel-based company said it had net income of 16 cents. The biopharmaceutical posted revenue of $35.7 million in the period. For the year, the company reported net ...


Kamada Reports Financial Results for Fourth Quarter and Full-Year 2017
Posted on Wednesday February 07, 2018

Total Revenues for Fiscal 2017 were $102.8 Million, up 33% Over Fiscal 2016; Exceeded Full-Year Revenue Guidance of $100 Million Full-Year Proprietary Products Revenues up 42% Year-Over-Year Gross Profit ...


Kamada to Announce Fiscal Year 2017 Financial Results and Host Conference Call on February 7
Posted on Friday February 02, 2018

REHOVOT, Israel, Feb. 02, 2018-- Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, today announced that it will release financial results for the fiscal year ended ...


Kamada Announces Interim Results from Phase 2 Clinical Trial of Intravenous Alpha-1 Antitrypsin Treatment for Prevention of Lung Transplant Rejection
Posted on Monday January 08, 2018

Kamada’ s IV AAT Demonstrated Favorable Safety and Tolerability Profile in 10 Patients During First Six Months of Treatment, Consistent with Previously Observed Results in Other Indications. Next Interim ...


Comparing ChemoCentryx (CCXI) and Kamada (KMDA)
The Lincolnian Online - Nov 10, 2017
Kamada logo Kamada Ltd. is an Israel-based biopharmaceutical company, which develops, produces and markets therapeutics, based on chromatographic purification technology.

Kamada to Announce Fiscal Year 2017 Financial Results and Host Conference Call ...
GlobeNewswire (press release) - Feb 2, 2018
Kamada Ltd. is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline.
Chardan Capital Markets Starts Kamada Ltd. (KMDA) at Buy - StreetInsider.com

Kamada Ltd.
MarketWatch - Dec 26, 2016
Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through two segments: Proprietary Products and Distribution.

Kedrion Biopharma and Kamada Receive FDA Approval of KEDRAB™ for Post ...
GlobeNewswire (press release) - Aug 25, 2017
25, 2017 (GLOBE NEWSWIRE) -- Kedrion Biopharma and Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), two leading human-derived protein therapeutics companies, today announced that KEDRAB™ [rabies immune globulin (Human)] has received U.S.
FDA Approves Rabies IgG. Available in Early 2018 - Rare Disease Report

Enter a stock symbol to view the stock details.